Preoperative lymphocyte to C-reactive protein ratio as a new prognostic indicator in patients with resectable gallbladder cancer

Hepatobiliary and Pancreatic Diseases International - Tập 21 - Trang 267-272 - 2022
Wen-Yan Yao1,2, Xiang-Song Wu1,2, Shi-Lei Liu1,2, Zi-You Wu1,2, Ping Dong1,2, Wei Gong1,2
1Department of General Surgery, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200092, China
2Shanghai Key Laboratory of Biliary Tract Disease Research, Shanghai 200092, China

Tài liệu tham khảo

Chen, 2018, Cancer incidence and mortality in China, 2014, Chin J Cancer Res, 30, 1, 10.21147/j.issn.1000-9604.2018.01.01 Wu, 2014, Evaluation of two inflammation-based prognostic scores in patients with resectable gallbladder carcinoma, Ann Surg Oncol, 21, 449, 10.1245/s10434-013-3292-z Kanthan, 2015, Gallbladder cancer in the 21st century, J Oncol, 2015, 10.1155/2015/967472 Hundal, 2014, Gallbladder cancer: epidemiology and outcome, Clin Epidemiol, 6, 99 Liu, 2019, BRD4 inhibitor and histone deacetylase inhibitor synergistically inhibit the proliferation of gallbladder cancer in vitro and in vivo, Cancer Sci, 110, 2493, 10.1111/cas.14102 Zhang, 2017, EIF3D promotes gallbladder cancer development by stabilizing GRK2 kinase and activating PI3K-AKT signaling pathway, Cell Death Dis, 8, e2868, 10.1038/cddis.2017.263 Sharma, 2017, Gallbladder cancer epidemiology, pathogenesis and molecular genetics: Recent update, World J Gastroenterol, 23, 3978, 10.3748/wjg.v23.i22.3978 Aloia, 2015, Gallbladder cancer: expert consensus statement, HPB (Oxford), 17, 681, 10.1111/hpb.12444 Crusz, 2015, Inflammation and cancer: advances and new agents, Nat Rev Clin Oncol, 12, 584, 10.1038/nrclinonc.2015.105 Diakos, 2014, Cancer-related inflammation and treatment effectiveness, Lancet Oncol, 15, e493, 10.1016/S1470-2045(14)70263-3 Espinoza, 2016, The inflammatory inception of gallbladder cancer, Biochim Biophys Acta, 1865, 245 Uribe-Querol, 2015, Neutrophils in cancer: two sides of the same coin, J Immunol Res, 2015, 10.1155/2015/983698 Shinji, 2018, Combined use of preoperative lymphocyte counts and the post/preoperative lymphocyte count ratio as a prognostic marker of recurrence after curative resection of stage II colon cancer, Oncotarget, 9, 2553, 10.18632/oncotarget.23510 Wan, 2013, Preoperative platelet count associates with survival and distant metastasis in surgically resected colorectal cancer patients, J Gastrointest Cancer, 44, 293, 10.1007/s12029-013-9491-9 Shrotriya, 2015, C-reactive protein is an important biomarker for prognosis tumor recurrence and treatment response in adult solid tumors: a systematic review, PLoS One, 10, 10.1371/journal.pone.0143080 Gupta, 2010, Pretreatment serum albumin as a predictor of cancer survival: a systematic review of the epidemiological literature, Nutr J, 9, 69, 10.1186/1475-2891-9-69 Toiyama, 2016, Clinical burden of C-reactive protein/albumin ratio before curative surgery for patients with gastric cancer, Anticancer Res, 36, 6491, 10.21873/anticanres.11248 Zhang, 2017, The elevated NLR, PLR and PLT may predict the prognosis of patients with colorectal cancer: a systematic review and meta-analysis, Oncotarget, 8, 68837, 10.18632/oncotarget.18575 Okugawa, 2020, Lymphocyte-C-reactive protein ratio as promising new marker for predicting surgical and oncological outcomes in colorectal cancer, Ann Surg, 272, 342, 10.1097/SLA.0000000000003239 Pang, 2015, Platelet to lymphocyte ratio as a novel prognostic tool for gallbladder carcinoma, World J Gastroenterol, 21, 6675, 10.3748/wjg.v21.i21.6675 Zhang, 2016, Prognostic significance of neutrophil to lymphocyte ratio in patients with gallbladder carcinoma, HPB (Oxford), 18, 600, 10.1016/j.hpb.2016.03.608 Zhu, 2019, Preoperative platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio as predictors of clinical outcome in patients with gallbladder cancer, Sci Rep, 9, 1823, 10.1038/s41598-018-38396-4 Amin, 2017 Joyce, 2015, T cell exclusion, immune privilege, and the tumor microenvironment, Science, 348, 74, 10.1126/science.aaa6204 Clark, 2007, Preoperative lymphocyte count as a prognostic factor in resected pancreatic ductal adenocarcinoma, HPB (Oxford), 9, 456, 10.1080/13651820701774891 Allin, 2009, Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer, J Clin Oncol, 27, 2217, 10.1200/JCO.2008.19.8440 Shrotriya, 2018, Serum C-reactive protein is an important and powerful prognostic biomarker in most adult solid tumors, PLoS One, 13, 10.1371/journal.pone.0202555 Lin, 2016, Intrahepatic cholangiocarcinoma prognostic determination using pre-operative serum C-reactive protein levels, BMC Cancer, 16, 792, 10.1186/s12885-016-2827-7 Chen, 2013, CA-125 level as a prognostic indicator in type I and type II epithelial ovarian cancer, Int J Gynecol Cancer, 23, 815, 10.1097/IGC.0b013e31828f7a24 Zwakman, 2017, Perioperative changes in serum CA125 levels: a prognostic factor for disease-specific survival in patients with ovarian cancer, J Gynecol Oncol, 28, e7, 10.3802/jgo.2017.28.e7 Liu, 2016, Serum CA125 is a novel predictive marker for pancreatic cancer metastasis and correlates with the metastasis-associated burden, Oncotarget, 7, 5943, 10.18632/oncotarget.6819 Wang, 2016, Prognostic significance of preoperative serum CA125, CA19-9 and CEA in gastric carcinoma, Oncotarget, 7, 35423, 10.18632/oncotarget.8770